InvestorsHub Logo
Followers 8
Posts 549
Boards Moderated 0
Alias Born 02/03/2017

Re: gestalt2 post# 32008

Sunday, 12/16/2018 7:43:10 PM

Sunday, December 16, 2018 7:43:10 PM

Post# of 232170
I’ll have to go back and listen to it a second time (obviously ha!). I had the same thought about where they are at with the company (build up as CYDY vs sell it off). Maybe they are using the pre-manufacturing and inventory build-up as a selling point, but at the same time pushing ahead to go it alone just in case. I like to think the real reason is to get Leronlimab to patients who desperately need it as soon as possible in anticipation of FDA approval, regardless.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News